Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study

[1]  L. Xue,et al.  Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach , 2020, Journal of Cancer Research and Clinical Oncology.

[2]  Guoxin Li,et al.  Implications of clinical research on adjuvant chemotherapy for gastric cancer: Where to go next? , 2019, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[3]  L. Shen,et al.  Genomic dissection of gastrointestinal and lung neuroendocrine neoplasm , 2019, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[4]  Haitao Zhao,et al.  Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma , 2019, EBioMedicine.

[5]  Chang-ming Huang,et al.  Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients , 2018, BMC Cancer.

[6]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[7]  R. van Hillegersberg,et al.  Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  P. Ruszniewski,et al.  Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms , 2017, Neuroendocrinology.

[9]  R. Lloyd,et al.  WHO classification of tumours of endocrine organs , 2017 .

[10]  Y. S. Park,et al.  Comparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma , 2017, Therapeutic advances in gastroenterology.

[11]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[12]  D. Coit,et al.  Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project , 2017, Gastric Cancer.

[13]  M. Hsieh,et al.  A nationwide cohort study , 2016 .

[14]  F. Sessa,et al.  Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms , 2016, Endocrine Pathology.

[15]  M. Poetsch,et al.  Neuroendocrine differentiation: The mysterious fellow of colorectal cancer. , 2015, World journal of gastroenterology.

[16]  A. Nicholson,et al.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  Yoon-Koo Kang,et al.  Prognostic significance of neuroendocrine components in gastric carcinomas. , 2014, European journal of cancer.

[18]  M. Fassan,et al.  Mixed Adenoneuroendocrine Carcinomas of the Gastrointestinal Tract: Targeted Next-Generation Sequencing Suggests a Monoclonal Origin of the Two Components , 2014, Neuroendocrinology.

[19]  D. Lambrechts,et al.  Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment. , 2014, Anticancer research.

[20]  H. Tsuda,et al.  Neuroendocrine Carcinoma of the Stomach: Morphologic and Immunohistochemical Characteristics and Prognosis , 2013, The American journal of surgical pathology.

[21]  F. Penault-Llorca,et al.  Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases , 2012, European journal of gastroenterology & hepatology.

[22]  R. Talamini,et al.  Exocrine and endocrine modulation in common gastric carcinoma. , 2012, American journal of clinical pathology.

[23]  F. Sessa,et al.  Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update , 2012, Cancers.

[24]  A. Vanoli,et al.  Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. , 2011, Human pathology.

[25]  Zu-hua Gao,et al.  Colorectal Glandular-Neuroendocrine Mixed Tumor: Pathologic Spectrum and Clinical Implications , 2011, The American journal of surgical pathology.

[26]  M. Papotti,et al.  Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas , 2010, Virchows Archiv.

[27]  M. Saegusa,et al.  Gastric Large Cell Neuroendocrine Carcinomas: A Distinct Clinicopathologic Entity , 2006, The American journal of surgical pathology.

[28]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[29]  Z. Qian,et al.  Histological and immunohistochemical study of composite neuroendocrine-exocrine carcinomas of the stomach. , 2005, The journal of medical investigation : JMI.

[30]  Seung‐Mo Hong,et al.  Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. , 2005, Human pathology.

[31]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[32]  Y. Ajioka,et al.  Carcinogenesis of gastric endocrine cell carcinoma: analysis of histopathology and p53 gene alteration , 2003, Gastric Cancer.

[33]  A. Iwashita,et al.  Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma. , 2003, Anticancer research.

[34]  G. Pelosi,et al.  Microallelotyping Defines the Monoclonal or the Polyclonal Origin of Mixed and Collision Endocrine-Exocrine Tumors of the Gut , 2003, Laboratory Investigation.

[35]  H. Matsubayashi,et al.  Advanced gastric glandular-endocrine cell carcinoma with 1-year survival after gastrectomy , 2000, Gastric Cancer.

[36]  E. Furth,et al.  Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. , 1997, Journal of the National Cancer Institute.

[37]  M. Rhyu,et al.  Genetic evidence for the multi-step progression of mixed glandular–neuroendocrine gastric carcinomas , 2014, Virchows Archiv.

[38]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[39]  W. Travis Pathology & Genetics Tumours of the lung, Pleura, Thymus and Heart , 2004 .

[40]  T. Stijnen,et al.  Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction. , 2004, International journal of surgical pathology.

[41]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[42]  J. Cooper Ajcc Cancer Staging Manual , 1997 .

[43]  J. A. Sulbarán Muñoz,et al.  [Neuroendocrine neoplasms of the digestive system]. , 1990, G.E.N.